Literature DB >> 4010792

Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception.

S O Ogren, O G Berge.   

Abstract

Administration of the serotonin (5-HT) releasing compound p-chloroamphetamine (PCA; 2.5 mg/kg) induced potent analgesia in rats tested with the hot plate method. The analgesia was prevented by pretreatment with either of the 5-HT uptake inhibitors alaproclate (20 mg/kg) or fluoxetine (10 mg/kg). Taking into account that the noradrenergic uptake inhibitor desipramine in previous experiments failed to interfere with the effect of PCA, these results demonstrate that PCA selectively acts on 5-HT terminals. The analgesia was attenuated by administration of the 5-HT antagonists methiothepin (0.125-0.5 mg/kg) and danitracen (0.25-2.5 mg/kg) but not by a series of other 5-HT receptor antagonists or antagonists acting on noradrenergic, dopaminergic, GABAergic, histaminergic or muscarinic receptors. It is concluded that the analgesic effect of PCA is mediated via stimulation of a type of 5-HT receptors possibly belonging to the 5-HT-1 class. Further studies are, however, needed in order to firmly establish the relationship to any particular sub-type of 5-HT receptor as characterized in in vitro binding studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010792     DOI: 10.1007/bf00501202

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism.

Authors:  J H Jacoby; R A Howd; M S Levin; R J Wurtman
Journal:  Neuropharmacology       Date:  1976-09       Impact factor: 5.250

2.  The action of compound WA-335 on the central nervous system.

Authors:  J Maj; L Baran; H Sowińska; L Gancarczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1976       Impact factor: 4.291

3.  Blockade of central 5-hydroxytryptamine receptors by methiothepin.

Authors:  M A Monachon; W P Burkard; M Jalfre; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input.

Authors:  H J Haigler; G K Aghajanian
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

5.  Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.

Authors:  S B Ross; S O Ogren; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-10

6.  Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex.

Authors:  M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

7.  Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat.

Authors:  S O Ogren
Journal:  Pharmacol Biochem Behav       Date:  1982-06       Impact factor: 3.533

8.  Selective lesions of the bulbospinal serotonergic pathways reduce the analgesia induced by p-chloroamphetamine in the hot-plate test.

Authors:  O G Berge; S O Ogren
Journal:  Neurosci Lett       Date:  1984-01-27       Impact factor: 3.046

9.  Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.

Authors:  S O Ogren; H Hall; C Köhler; O Magnusson; L O Lindbom; K Angeby; L Florvall
Journal:  Eur J Pharmacol       Date:  1984-07-20       Impact factor: 4.432

10.  Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists.

Authors:  H K Proudfit; D L Hammond
Journal:  Brain Res       Date:  1981-08-10       Impact factor: 3.252

View more
  4 in total

1.  Mechanisms by which the putative serotonin receptor antagonist metitepin alters nociception in mice.

Authors:  P K Eide; K Hole; O G Berge
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Development of tolerance to the antinociceptive effect of metergoline.

Authors:  O B Fasmer; O G Berge; K Hole
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function.

Authors:  S O Ogren; C Johansson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.

Authors:  S O Ogren; S Carlsson; T Bartfai
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.